ITM, which is based in Munich, Germany, is both supplier and drug developer. The firm has a close relationship with Novartis and supplies the raw materials needed to make Pluvicto, a prostate ...
The sites in Munich and Boston will be shut down by the end of next year. At the time the acquisition was announced, Novartis highlighted pelabresib, a BET inhibitor that recently generated mixed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback